Topgene Biotechnology

Topgene Biotechnology, also known as Hubei Topgene Biotechnology Group, is a leading Chinese contract research organization (CRO) specializing in preclinical drug research and evaluation. Founded in 2009 and headquartered in Wuhan's Biolake, the company is globally recognized for its expertise in non-human primate (NHP) models and large animal testing. Its integrated service portfolio encompasses NHP breeding, human disease animal model construction, pharmacology, pharmacokinetics (PK/PD), toxicology, and GLP-compliant safety assessments. Topgene operates several specialized subsidiaries, including Topgene Xinsheng and Topgene Xinchen, and holds major international accreditations such as NMPA GLP and full AAALAC International certification. The company supports the development of advanced therapeutic modalities, including monoclonal antibodies, cell and gene therapies, and mRNA vaccines, for clients across the pharmaceutical and biotechnology sectors.